ENTITY
Novartis

Novartis (NOVN SW)

48
Analysis
Health CareSwitzerland
Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis offers patent protected prescription medicine and generic pharmaceuticals and biosimilars.
more
bullishNovartis
04 Nov 2024 16:00

Novartis AG: Cardiovascular Disease Portfolio Expansion As A Critical Growth Catalyst! - Major Drivers

Novartis has reported a robust operational performance in its third quarter of 2024, reflecting a continuation of positive trends over the past...

Logo
154 Views
Share
bullishNovartis
27 Jul 2024 01:00

Novartis AG (NVS): Acquisition of Mariana Oncology for Expansion of Oncology Portfolio

Novartis's second quarter 2024 earnings were decent and revealed a company strongly positioned and confident of its continued growth...

Logo
340 Views
Share
bullishNovartis
30 Apr 2024 15:00

Novartis AG: Positive Expectations for Scemblix & 5 Other Major Developments

In Q1 2024, Novartis delivered robust growth, reflecting in a double-digit sales growth and core margin expansion. Sales were up by 11% in...

Logo
192 Views
Share
bullishNovartis
09 Feb 2024 01:00

Novartis AG: Can The Acquisition of MorphoSys AG Really Strengthen Its Oncology Pipeline? - Major Drivers

Based on the earnings call transcript from the Q4 2023 Novartis, the company delivered a strong full-year performance with margin expansion and...

Logo
236 Views
Share
bullishMorphoSys AG
07 Feb 2024 07:54

Novartis Strikes for Possible Myelofibrosis Blockbuster

​Novartis offers premium for MorphoSys AG in a bet on pelabrisib as a potential blockbuster for myelofibrosis treatment. Shareholders are likely to...

Share
x